Denton David M
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Pfizer Declares 352nd Straight Dividend, Holds Steady Amid Vaccine Selloff. Pfizer announced its 352nd consecutive quarterly dividend, keeping a yield of about 5.4%. The company’s share price has stayed flat even as other vaccine makers like Novavax and Moderna fell. A new approval for the drug Tukysa could alter the company’s outlook, and analysts are watching the upcoming Q3 2026 earnings report for more detail.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
LVMH Q3 China Slowdown; Kate Spade Targets Gen Z. LVMH reported that its Fashion & Leather Goods division saw organic sales decline by 5% in Q3, citing a demand slowdown in China. This macro headwind is relevant to Tapestry, which also operates in the luxury sector. Meanwhile, Kate Spade CEO Eva Erdmann is focusing on the brand's heritage to attract younger Gen Z customers.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Lowe's Highlights Dividend Status and Black Friday Changes. Lowe's has been highlighted as a dividend champion contender, drawing attention to its stable yield. The retailer announced major Black Friday changes that could shift shopper behavior, while average ticket growth helps offset softer visits. Analysts keep a target range of $190 to $300, reflecting ongoing interest in the company's performance.
Transaction History
| NKE | ▲ Buy | Grant | 71,234 | $0 | 9/1/2026 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 12,107 | $347K | 5/31/2024 | View on chart |
| PFE | ▼ Sell | Tax Withholding | 16,223 | $617K | 5/31/2023 | View on chart |
| TPR | ▲ Buy | Grant | 2,430 | $85K | 11/15/2022 | View on chart |
| PFE | ▲ Buy | Grant | 61,275 | $0 | 5/31/2022 | View on chart |
| LOW | ▲ Buy | Grant | 5,350 | $0 | 4/1/2022 | View on chart |
| LOW | ▲ Buy | Option Exercise | 38,220 | $0 | 4/1/2022 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 21,230 | $4.3M | 4/1/2022 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 3,737 | $966K | 1/2/2022 | View on chart |
| TPR | ▲ Buy | Grant | 1,793 | $75K | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nike shares rise amid value interest and Foot Locker split
Nike stock rose 5% recently as investors focused on its value metrics, despite a lack of major corporate announcements. The company has also ended its partnership with Foot Locker, a move that may impact its retail shelf presence. While only 26% of analysts currently rate the stock a Buy, the average price target remains below the current trading range.
Nike shares rise amid value interest and Foot Locker split. Nike stock rose 5% recently as investors focused on its value metrics, despite a lack of major corporate announcements. The company has also ended its partnership with Foot Locker, a move that may impact its retail shelf presence. While only 26% of analysts currently rate the stock a Buy, the average price target remains below the current trading range.